SOBRsafe Launches Revolutionary Alcohol Detection Software: Transforming Patient Care for Behavioral Health Providers
SOBRsafe Launches Revolutionary Alcohol Detection Software: Transforming Patient Care for Behavioral Health Providers
SOBRsafe Launches Revolutionary Alcohol Detection Software: Transforming Patient Care for Behavioral Health Providers
SobrSafe推出革命性的酒精檢測軟件:改變行爲健康提供者的患者護理
DENVER, CO / ACCESSWIRE / October 22, 2024 / SOBRsafe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), the leader in next-generation transdermal alcohol detection technology, is proud to announce the launch of its fully-integrated enterprise software solution for point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure). This new innovative platform is expected to transform how health providers monitor and manage alcohol compliance, delivering unprecedented real-time visibility across multiple users and locations in one dynamic dashboard.
科羅拉多州丹佛/ACCESSWIRE /2024年10月22日/下一代透皮酒精檢測技術的領導者SOBRSafe, Inc.(納斯達克股票代碼:SOBR)(「SOBRSafe」)自豪地宣佈推出其用於牀旁篩查的完全集成的企業軟件解決方案 (sobrCheck) 和持續監控 (SobrSure)。這個新的創新平台有望改變醫療服務提供者監測和管理酒精合規性的方式,在一個動態儀表板中爲多個用戶和地點提供前所未有的實時可見性。
"We created the SOBRsafe enterprise software to address the significant challenges experienced by behavioral health centers and providers across the country," stated David Gandini, CEO of SOBRsafe. "By integrating our technologies into an effective and user-friendly dashboard, we equip users with powerful monitoring tools to drive positive outcomes while significantly impacting organizational efficiency."
SobrSafe首席執行官戴維·甘迪尼表示:「我們創建了SobrSafe企業軟件,以應對全國各地的行爲健康中心和提供者所面臨的重大挑戰。」「通過將我們的技術集成到有效且用戶友好的儀表板中,我們爲用戶提供了強大的監控工具,以推動取得積極成果,同時顯著影響組織效率。」
The current methods for monitoring alcohol use are outdated and inefficient. They rely on invasive, unhygienic, physical testing and printed reports which can delay interventions and negatively impact patient care. SOBRsafe's transdermal alcohol detection devices, combined with the integrated enterprise software platform, offers a comprehensive solution. The advanced touch-based technology detects alcohol emitted through the skin, eliminating the need for breath, blood, or urine samples. Information is instantly reported and accessible via computer or mobile device, allowing providers to monitor hundreds of patients across various locations through a streamlined digital dashboard. This setup ensures immediate visibility into any detected alcohol use, enabling timely interventions and support.
目前監測酒精使用情況的方法已經過時且效率低下。他們依賴侵入性、不衛生的物理測試和印刷報告,這可能會延遲干預措施並對患者護理產生負面影響。SobrSafe 的透皮酒精檢測設備與集成的企業軟件平台相結合,提供了全面的解決方案。先進的觸控技術可檢測通過皮膚排放的酒精,無需採集呼吸、血液或尿液樣本。信息可即時報告並通過計算機或移動設備進行訪問,從而使提供商能夠通過簡化的數字儀表板對不同地點的數百名患者進行監測。這種設置可確保立即看到任何檢測到的酒精使用情況,從而能夠及時進行干預和支持。
SOBRsafe's innovative software offers real-time insights into alcohol use throughout the treatment journey, creating the first definitive electronic alcohol record across the continuum of care. The new software integrates device data into an intuitive desktop interface with user-friendly navigation, allowing health providers to aggregate all activities onto a single screen. This significantly enhances responsiveness and reduces recidivism, providing hope for improved patient outcomes.
SobrSafe的創新軟件可實時了解整個治療過程中的酒精使用情況,從而創建了整個護理過程中的第一份權威電子酒精記錄。新軟件將設備數據集成到具有用戶友好導航功能的直觀桌面界面中,允許醫療服務提供者將所有活動彙總到一個屏幕上。這顯著增強了反應能力並減少了再犯率,爲改善患者預後提供了希望。
Moving beyond localized management, this software empowers providers to take holistic views of their organization. Moreover, the software features robust lookback capabilities that demonstrate historical performance and activity, a crucial ability for individuals needing to show compliance with third parties.
除了本地化管理之外,該軟件還使提供商能夠全面了解其組織。此外,該軟件具有強大的回顧功能,可以展示歷史表現和活動,這對於需要證明第三方合規性的個人來說是一項至關重要的能力。
"SOBRsafe technology has transformed our operations," said Keenen Diamond, President of Oceanfront Recovery. "Now, all clients can be monitored from one platform - with the integration of the SOBRsafe dashboard into our electronic medical records (EMR), we will make the final step towards absolute efficiency for our team and accountability for our staff. This integration will save us time and significantly improve our ability to support client recovery, whether inpatient or outpatient."
海濱恢復總裁基嫩·戴蒙德說:「SobrSafe技術改變了我們的運營。」「現在,所有客戶都可以通過一個平台進行監控——通過將SOBRSafe儀表板集成到我們的電子病歷(EMR)中,我們將朝着團隊的絕對效率和對員工的問責制邁出最後一步。這種整合將爲我們節省時間,並顯著提高我們支持客戶康復的能力,無論是住院患者還是門診患者。」
The launch of the enterprise software marks a significant milestone in SOBRsafe's continued evolution and mission to enhance accountability and support recovery. By equipping behavioral health providers with this innovative and efficient solution, the Company is setting a new standard for monitoring and managing alcohol compliance, ultimately transforming the treatment of addiction and alcohol use disorder (AUD).
企業軟件的推出標誌着SOBRSafe持續發展和使命中的一個重要里程碑,其使命是加強問責制和支持恢復。通過爲行爲健康提供者提供這種創新而有效的解決方案,該公司正在爲監測和管理酒精合規性設定新的標準,最終改變成癮和酒精使用障礙(AUD)的治療方式。
To learn more about SOBRsafe's enterprise software for behavioral health centers, visit sobrsafe.com/technology.
要了解有關SobrSafe行爲健康中心企業軟件的更多信息,請訪問sobrsafe.com/technology。
ABOUT SOBRsafe
關於 SOBRSafe
Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic and unconnected. There is a better way. Enter SOBRsafe. Our advanced transdermal (touch-based) technology detects and instantaneously reports the presence of alcohol as emitted through a user's skin - no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for the behavioral health, judicial and consumer markets, and for licensing and integration. The SOBRsafe technology is commercially available for point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure). At SOBRsafe, our mission is to create better outcomes and save lives. To learn more, visit sobrsafe.com.
酒精濫用是美國第四大可預防死亡原因,也是全球第七大死因。然而,預防和監測解決方案並未跟上這種流行病的步伐。傳統技術具有侵入性、效率低下、不衛生且互不相連。有更好的方法。輸入 sobrSafe。我們先進的透皮(觸摸式)技術可檢測並即時報告通過用戶皮膚排放的酒精的存在,無需進行呼吸、血液或尿液樣本。憑藉強大的後端數據平台,SOBRSafe爲行爲健康、司法和消費者市場以及許可和整合提供下一代被動檢測技術。SOBRSafe技術已上市,可用於牀旁篩查(SOBRCheck)和持續監測(SobrSure)。在SobrSafe,我們的使命是創造更好的結果並拯救生命。要了解更多信息,請訪問 sobrsafe.com。
PRESS CONTACT
新聞聯繫人
Amber Sabri
amber@stanton-company.com
610.509.8258
安伯·薩布里
amber@stanton-company.com
610.509.8258
Safe Harbor Statement
安全港聲明
Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. The Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing Sections. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this presentation. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. We caution readers not to place undue reliance upon any such forward-looking statements. The Company does not undertake to publicly update or revise forward-looking statements, whether because of new information, future events or otherwise. Additional information respecting factors that could materially affect the Company and its operations are contained in the Company's filings with the SEC which can be found on the SEC's website at www.sec.gov.
我們在SobrSafe的前景受到不確定性和風險的影響。本新聞稿包含1933年《證券法》第27A條和1934年《證券法》第21E條所指的前瞻性陳述。公司打算將此類前瞻性陳述置於前述各節提供的安全港的約束。這些前瞻性陳述主要基於對未來事件的預期或預測,可能受到不準確假設的影響,並受到各種業務風險以及已知和未知的不確定性的影響,其中許多不確定性是管理層無法控制的。因此,實際業績可能與本演示文稿中包含的前瞻性陳述存在重大差異。公司無法事後預測或確定哪些因素會導致實際業績與前瞻性陳述或其他陳述所示結果存在重大差異。讀者應將包含 「相信」、「期望」、「預期」、「打算」、「計劃」、「項目」、「應該」 等詞語或其他預測或表明未來事件或趨勢的表述視爲不確定和具有前瞻性的陳述。我們提醒讀者不要過分依賴任何此類前瞻性陳述。無論是由於新信息、未來事件還是其他原因,公司均不承諾公開更新或修改前瞻性陳述。有關可能對公司及其運營產生重大影響的因素的更多信息包含在公司向美國證券交易委員會提交的文件中,該文件可在美國證券交易委員會的網站www.sec.gov上找到。
SOURCE: SOBR Safe, Inc.
來源:SOBR Safe, Inc.
Released October 22, 2024
2024 年 10 月 22 日發佈